Literature DB >> 11503949

Cerebrovascular and cardiovascular responses associated with orthostatic intolerance and tachycardia.

M P Harms1, J J van Lieshout.   

Abstract

Idiopathic orthostatic intolerance syndrome is characterized by postural symptoms of cerebral hypoperfusion without arterial hypotension. Abnormal baroreceptor responses with deranged cerebral autoregulation leading to cerebral vasoconstriction have been proposed as a causative mechanism. The authors report the cerebrovascular and cardiovascular responses in a patient who recovered from orthostatic intolerance and tachycardia. Changes in the orthostatic responses of mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), and transcranial Doppler middle cerebral artery (MCA) mean blood flow velocity (Vmean) were assessed at admission and again 6 months after recovery. Normal cardiovascular responses to forced breathing and to standing indicated intact overall baroreflex integrity with normal baroreflex sensitivity (10.2 msec.mm Hg(-1)). After the patient stood for 8 minutes, presyncopal symptoms developed, with unchanged MAP but increased HR (+41 beats/min) and reduced stroke volume (SV) (-69%), CO (-50%), and MCA Vmean (-46%; 57 to 31 cm. s(-1)). After a reconditioning program and recovery, the patient was reexamined. The supine MCA Vmean was larger (79 cm. s(-1)), as were MAP (76 versus 70 mm Hg) and CO (+15%). The orthostatic HR increase was smaller (+5 beats/min), as was the reduction in SV (-44%) and CO (-30%), with an increase in MAP to 93 mm Hg. The orthostatic reduction in MCA Vmean was smaller (-13 versus -26 cm.s(-1)) and standing cerebrovascular resistance decreased (1.41 versus 2.39 mm Hg.cm. s(-1)). In this patient who had intact baroreflex control and no postural decrease in blood pressure, the reduction in MCA Vmean, concomitant with a large decrease in CO, seemed reversible. The result suggests that a symptomatic reduction in cerebrovascular conductance during standing is to be interpreted as being an adaptive response to a critically limited systemic blood flow, rather than to derangement of cerebral autoregulation.

Entities:  

Mesh:

Year:  2001        PMID: 11503949     DOI: 10.1007/bf02317800

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  39 in total

1.  Diagnosis of tachycardia syndromes associated with orthostatic symptoms.

Authors:  S Braune; C Wrocklage; J Schulte-Mönting; R Schnitzer; C H Lücking
Journal:  Clin Auton Res       Date:  1999-04       Impact factor: 4.435

2.  Non-invasive blood pressure monitoring during head-up tilt using the Penaz principle.

Authors:  D B Friedman; F B Jensen; S Matzen; N H Secher
Journal:  Acta Anaesthesiol Scand       Date:  1990-10       Impact factor: 2.105

3.  Continuous cardiac output in septic shock by simulating a model of the aortic input impedance: a comparison with bolus injection thermodilution.

Authors:  W T Jellema; K H Wesseling; A B Groeneveld; C P Stoutenbeek; L G Thijs; J J van Lieshout
Journal:  Anesthesiology       Date:  1999-05       Impact factor: 7.892

4.  Near-infrared spectrophotometry determined brain oxygenation during fainting.

Authors:  P Madsen; F Pott; S B Olsen; H B Nielsen; I Burcev; N H Secher
Journal:  Acta Physiol Scand       Date:  1998-04

5.  Training induced effects on blood volume, erythrocyte turnover and haemoglobin oxygen binding properties.

Authors:  W Schmidt; N Maassen; F Trost; D Böning
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

6.  Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance.

Authors:  G Jacob; J R Shannon; F Costa; R Furlan; I Biaggioni; R Mosqueda-Garcia; R M Robertson; D Robertson
Journal:  Circulation       Date:  1999-04-06       Impact factor: 29.690

7.  Middle cerebral artery blood velocity depends on cardiac output during exercise with a large muscle mass.

Authors:  K Ide; F Pott; J J Van Lieshout; N H Secher
Journal:  Acta Physiol Scand       Date:  1998-01

8.  Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension.

Authors:  L A Lipsitz; S Mukai; J Hamner; M Gagnon; V Babikian
Journal:  Stroke       Date:  2000-08       Impact factor: 7.914

9.  Orthostatic tolerance, cerebral oxygenation, and blood velocity in humans with sympathetic failure.

Authors:  M P Harms; W N Colier; W Wieling; J W Lenders; N H Secher; J J van Lieshout
Journal:  Stroke       Date:  2000-07       Impact factor: 7.914

10.  Effects of standing on cerebrovascular resistance in patients with idiopathic orthostatic intolerance.

Authors:  G Jacob; D Atkinson; J Jordan; J R Shannon; R Furlan; B K Black; D Robertson
Journal:  Am J Med       Date:  1999-01       Impact factor: 4.965

View more
  5 in total

Review 1.  Transcranial Doppler for evaluation of cerebral autoregulation.

Authors:  Ronney B Panerai
Journal:  Clin Auton Res       Date:  2009-04-16       Impact factor: 4.435

2.  NET silencing by let-7i in postural tachycardia syndrome.

Authors:  Abdul Waheed Khan; Mark Ziemann; Susan J Corcoran; Harikrishnan K N; Jun Okabe; Haloom Rafehi; Scott S Maxwell; Murray D Esler; Assam El-Osta
Journal:  JCI Insight       Date:  2017-03-23

3.  Reduced central blood volume and cardiac output and increased vascular resistance during static handgrip exercise in postural tachycardia syndrome.

Authors:  Julian M Stewart; Indu Taneja; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-06       Impact factor: 4.733

4.  The postural reduction in middle cerebral artery blood velocity is not explained by PaCO2.

Authors:  R V Immink; N H Secher; C M Roos; F Pott; P L Madsen; J J van Lieshout
Journal:  Eur J Appl Physiol       Date:  2006-02-10       Impact factor: 3.078

Review 5.  Central Hypovolemia Detection During Environmental Stress-A Role for Artificial Intelligence?

Authors:  Björn J P van der Ster; Yu-Sok Kim; Berend E Westerhof; Johannes J van Lieshout
Journal:  Front Physiol       Date:  2021-12-15       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.